Launch of Patient Advisory Board (CRS & Asthma)

Giving a voice to patient with chronic rhinosinusitis and asthma

Despite the high prevalence of chronic rhinosinusitis (CRS) in Europe and its impact on patients’ quality of life, no European patient organization for CRS currently exists.

To fill this gap and give a voice to CRS patients, EUFOREA has created a patient advisory board, whose goal is to better understand the needs of patients, the emotional and financial impact of the illness, and to raise awareness at a political level while working together on novel solutions for timely access to treatments.